24.11.2025 17:12 | Euronews World
Shares of Danish pharmaceutical giant Novo Nordisk fell sharply after its Alzheimer's drug failed to slow progression of the disease in a trial. Meanwhile, Germany's Bayer said their stroke-prevention drug showed positive results, pushing the share price through the roof.
🔗 Citește articolul complet pe Euronews World18.10.2026 17:42 | Fanatik
18.10.2026 17:41 | Fanatik
18.10.2026 17:33 | Prosport
18.10.2026 17:32 | Prosport
18.10.2026 17:31 | Antena 3 CNN
18.10.2026 17:28 | Sport.ro